March 23–25, 2026
FIL (Feira Internacional de Lisboa), Lisbon, PortugalMarch 31 – April 1, 2026 | Digital Partnering Thomas KimCEO at EpiVario Inc.Presenter
Profile
Thomas Kim is the President & CEO of EpiVario. He is an experienced biotech executive and corporate attorney, and a registered patent attorney. Prior to EpiVario, he served as SVP and Corporate Secretary for public biopharmaceutical company, Inovio Pharmaceuticals, where he built a global biotechnology patent portfolio, led the company through various M&A transactions, and closed several licenses and partnering deals with large pharmaceutical companies. He also serves on the External Advisory Board of Georgia Tech College of Science, and on the Board of Directors of the nonprofit TANGO2 Research Foundation.